The drug was developed by Sage Therapeutics in collaboration with another pharmaceutics company, Biogen.
The former was also given FDA approval for an intravenous version of a similar drug in 2019, which is not used widely due to its high price tag and the difficulty of administration ; talking therapy; and self-help .
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: